You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Resource added for the Nursing-Associate Degree 105431, Practical Nursing 315431, and Nursing Assistant 305431 programs.
Antipsychotic medications are a key treatment for schizophrenia and sales of antipsychotic drugs approach $20 billion per year, with fierce marketing between the makers of the drugs. The U.S. National Institute of Mental Health sponsored the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project to provide independent information about the comparative effectiveness of medications. CATIE was the largest, longest and most comprehensive study of schizophrenia to date. Conducted under rigorous double-blind conditions, Antipsychotic Trials in Schizophrenia presents the definitive archival results of this landmark study. The core of the book consists of chapters focused on specific outcomes that set the CATIE findings in a wider context. Also included are chapters on the design, statistical analyses and implications for researchers, clinicians and policy makers. Psychiatrists, psychiatric researchers, mental health policy makers and those working in pharmaceutical companies will all find this to be essential reading.
"Schizophrenia remains the most challenging of mental disorders confronted by psychiatrists and other mental health providers. Its primary manifestations-psychotic symptoms and cognitive impairment-profoundly affect the functioning of individuals with schizophrenia. This is an updated textbook covering the current state of knowledge about schizophrenia, including its causes, nature, presentation, and treatment. Chapters are written by a roster of experts in "--
Antipsychotic medications are a key treatment for schizophrenia and sales of antipsychotic drugs approach $20 billion per year, with fierce marketing between the makers of the drugs. The U.S. National Institute of Mental Health sponsored the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project to provide independent information about the comparative effectiveness of medications. CATIE was the largest, longest and most comprehensive study of schizophrenia to date. Conducted under rigorous double-blind conditions, Antipsychotic Trials in Schizophrenia presents the definitive archival results of this landmark study. The core of the book consists of chapters focused on specific outcomes that set the CATIE findings in a wider context. Also included are chapters on the design, statistical analyses and implications for researchers, clinicians and policy makers. Psychiatrists, psychiatric researchers, mental health policy makers and those working in pharmaceutical companies will all find this to be essential reading.
Schizophrenia is one of the most difficult diagnoses to make. And, once made, it was once among the most limited, offering few options in the management of care for schizophrenia patients with comorbid conditions. It was not until 1994, with the publication of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), that diagnostic guidelines first permitted additional diagnoses on Axis I, such as anxiety disorder, in the presence of schizophrenia. Yet remnants of the old hierarchical diagnostic system remain, diverting attention from the pressing issue of managing what appear to be common -- and treatable -- disabling conditions, such as panic disorder and obsessi...
"First Published in 1997, Routledge is an imprint of Taylor & Francis, an informa company."
The rapid spread of managed care into public and community mental health systems is creating a dramatic transformation of traditional public sector settings. This radical change is affecting administrators, managers, and clinicians.Intended as a survival manual, this book begins with an overview of the history, concepts, ideology, and ethics of public sector managed care and then proceeds in focus from system to program management to clinical program levels. With a concluding section on advocacy, evaluation, research, and training issues, Managed Mental Health Care in the Public Sector examines how public sector managed mental health care can be approached with a positive spirit, an excitement about the potential to create dramatic and beneficial system changes, and a genuine interest in investigating the relative merits of every aspect of managed care systems.
The aphorism that madness and creative genius are opposing sides of the same coin predates contemporary psychiatry and has existed since the time of the great Stagirite Aristotle. Schizophrenia is one mental disorder intimately linked with creative thinking and achievement. There is no shortage of eminent scientists, thinkers, writers, artists, composers, and political activists tentatively theorized to have precariously balanced the great divide between the demons of schizophrenia and the muses of creative illumination, including Rene Descartes, Emanuel Swedenborg, John Forbes Nash, Leonardo da Vinci, and Joan of Arc, to name but a few. However, is that association veracious in an empirical sense? If it is, how exactly are schizophrenia and creative illumination related? Using new empirical findings, this book sheds new light upon the age-old assumption and goes further still in explaining how creative potential with world-fashioning powers can be channelled in individuals with this diagnosis. Mental health practitioners will find this book both intriguing and useful.